Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality inmen and women: two prospective cohort studies

被引:467
作者
Madsen, Christian M. [1 ,2 ,3 ]
Varbo, Anette [1 ,2 ,3 ]
Nordestgaard, Borge G. [1 ,2 ,3 ,4 ]
机构
[1] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark
[2] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Herlev Ringvej 75, DK-2730 Herlev, Denmark
[3] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark
基金
英国医学研究理事会;
关键词
Lipids; Lipoproteins; HDL; Mortality; General population; Epidemiology; ISCHEMIC-HEART-DISEASE; HDL CHOLESTEROL; RISK-FACTOR; INDIVIDUALS; MUTATIONS; MEN;
D O I
10.1093/eurheartj/ehx163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims High-density lipoprotein (HDL) cholesterol concentrations are inversely associated with cardiovascular disease and mortality across a range of concentrations, but genetic evidence suggest that extreme high concentrations may paradoxically lead to more cardiovascular disease. We tested the hypothesis that extreme high concentrations of HDL cholesterol are associated with high all-cause mortality in men and women. Methods and results A total of 52 268 men and 64 240 women were included from the two prospective population-based studies, the Copenhagen City Heart Study and the Copenhagen General Population Study. During 745 452 person-years of follow-up, number of deaths from any cause were 5619 (mortality rate, 17.1/1000 person-years (95% confidence interval (CI): 16.7-17.6)) in men and 5059 (mortality rate, 12.1/1000 person-years (11.8-12.4)) in women. The association between HDL cholesterol concentrations and all-cause mortality was U-shaped for both men and women, with both extreme high and low concentrations being associated with high all-cause mortality risk. The concentration of HDL cholesterol associated with the lowest all-cause mortality was 1.9mmol/L (95% CI: 1.4-2.0) (73 mg/dL (54-77)) in men and 2.4mmol/L (1.8-2.5) (93mg/dL (69-97)) in women. When compared with the groups with the lowest risk, the multi-factorially adjusted hazard ratios for all-cause mortality were 1.36 (95% CI: 1.09-1.70) for men with HDL cholesterol of 2.5-2.99mmol/L (97-115 mg/dL) and 2.06 (1.44-2.95) for men with HDL cholesterol >= 3.0 mmol/L (116 mg/dL). For women, corresponding hazard ratios were 1.10 (0.83-1.46) for HDL cholesterol of 3.0-3.49mmol/L (116-134mg/dL) and 1.68 (1.09-2.58) for HDL cholesterol >= 3.5 mmol/L (135 mg/dL). Conclusion Men and women in the general population with extreme high HDL cholesterol paradoxically have high all-cause mortality. These findings need confirmation in other studies.
引用
收藏
页码:2478 / 2486
页数:9
相关论文
共 24 条
  • [1] Change in Body Mass Index Associated With Lowest Mortality in Denmark, 1976-2013
    Afzal, Shoaib
    Tybjaerg-Hansen, Anne
    Jensen, Gorm B.
    Nordestgaard, Borge G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (18): : 1989 - 1996
  • [2] Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene
    Agerholm-Larsen, B
    Nordestgaard, BG
    Steffensen, R
    Jensen, G
    Tybjærg-Hansen, A
    [J]. CIRCULATION, 2000, 101 (16) : 1907 - 1912
  • [3] Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease -: The Copenhagen City Heart Study
    Andersen, RV
    Wittrup, HH
    Tybærg-Hansen, A
    Steffensen, R
    Schnohr, P
    Nordestgaard, BG
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) : 1972 - 1982
  • [4] [Anonymous], 2009, Global health risks: mortality and burden of disease attributable to selected major risks
  • [5] Effects of torcetrapib in patients at high risk for coronary events
    Barter, Philip J.
    Caulfield, Mark
    Eriksson, Mats
    Grundy, Scott M.
    Kastelein, John J. P.
    Komajda, Michel
    Lopez-Sendon, Jose
    Mosca, Lori
    Tardif, Jean-Claude
    Waters, David D.
    Shear, Charles L.
    Revkin, James H.
    Buhr, Kevin A.
    Fisher, Marian R.
    Tall, Alan R.
    Brewer, Bryan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2109 - 2122
  • [6] High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among US Veterans
    Bowe, Benjamin
    Xie, Yan
    Xian, Hong
    Balasubramanian, Sumitra
    Zayed, Mohamed A.
    Al-Aly, Ziyad
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (10): : 1784 - 1793
  • [7] Clarke R, 1999, AM J EPIDEMIOL, V150, P341
  • [8] Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
  • [9] Genetic variation in ABCA1 predicts ischemic heart disease in the general population
    Frikke-Schmidt, Ruth
    Nordestgaard, Borge G.
    Jensen, Gorm B.
    Steffensen, Rolf
    Tybjaerg-Hansen, Anne
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (01) : 180 - 186
  • [10] Genetic Inhibition of CETP, Ischemic Vascular Disease and Mortality, and Possible Adverse Effects
    Johannsen, Trine Holm
    Frikke-Schmidt, Ruth
    Schou, Jesper
    Nordestgaard, Borge G.
    Tybjaerg-Hansen, Anne
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (20) : 2041 - 2048